Library
sunstone.euCrawled Oct 24, 2026
Product
6 pages- DiogenX/diogenx
DiogenX is a preclinical biotech company developing biologics as new treatment options for diabetic patients worldwide.
- Neumirna/neumirna-2
Neumirna Therapeutics is a biotechnology company developing RNA‑based therapies for neurological disorders dedicated to transforming patients’ lives.
- Oblique/oblique
Oblique Therapeutics AB (Gothenburg, Sweden) holds a novel antibody platform that allows the identification of new therapeutic antibodies towards targets that cannot be addressed with traditional antibody technology.
- Rewind Therapeutics/rewind-therapeutics
Rewind Therapeutics´ highly experienced, international team has established a leading-edge knowledge base in the field of remyelination.
Blog
6 pages- Beating the odds/beating-the-odds
- Best country for sourcing new deals?/best-country-for-sourcing-new-deals
- Increasing the investor return multiple with an IPO?/increasing-the-investor-return-multiple-with-an-ipo
- Modest interest in Human Safety!?/modest-interest-in-human-safety
Press
6 pages- Ascelia Pharma publishes prospectus in connection with Initial Public Offering on Nasdaq Stockholm/ascelia-pharma-publishes-prospectus-in-connection-with-initial-public-offering-on-nasdaq-stockholm
by Sunstone Life Science Ventures | Feb 21, 2019
- Ascelia Pharma’s new share issue in connection with the IPO on Nasdaq Stockholm was significantly oversubscribed/ascelia-pharmas-new-share-issue-in-connection-with-the-ipo-on-nasdaq-stockholm-was-significantly-oversubscribed
by Sunstone Life Science Ventures | Mar 7, 2019
- Sunstone announce new corporate structure and brand names/sunstone-announce-new-corporate-structure-and-brand-names
by Sunstone Life Science Ventures | Feb 14, 2019
- Sunstone Life Science Ventures fund IV announces first close/sunstone-life-science-ventures-fund-iv-announces-first-close
by Sunstone Life Science Ventures | Feb 7, 2019
Careers & Hiring
1 page- Sunstone Life Science Ventures is looking for a Student Assistant/sunstone-life-science-ventures-is-looking-for-a-student-assistant-2
by Sunstone Life Science Ventures | 04/01/2022
Team
6 pages- A Sunstone team update/a-sunstone-team-update
by Sunstone Life Science Ventures | 01/02/2024
- Business Development Advisory Board/business-development-board
The BDB meets twice a year, and selected portfolio companies are invited to participate based on company life cycle status and anticipated business events.
- Line Jacobsen - Management Assistant/people/line-jacobsen
Line Jacobsen, Management Assistant, with focus on Office Management and Administration.
- Merete Lundbye Møller – Venture Partner/people/merete-lundbye-moeller
Merete Lundbye Møller, focuses on legal affairs and corporate governance, and is typically engaged in all stages of the investment process.
About
6 pages- Are we making a tangible difference?/are-we-making-a-tangible-difference
- CSR Policy/csr-policy
Sunstone Life Science Ventures A/S supports Invest Europe, Active Owners, and similar groups in promoting ethical standards and best practices for venture investors.
- Funds/funds
Sunstone manages its portfolio through multiple funds, including Fund IV, which focuses exclusively on therapeutics.
- Sunstone has supported and funded companies that have been the originator of 20 life-changing products/sunstone-has-supported-and-funded-companies-that-have-been-the-originator-of-20-life-changing-products
Homepage
1 page- Homepage/
Sunstone Life Science Ventures is a European venture capital firm specializing in life science therapeutics.
